Shares Outstanding: 32.8m (latest)
Cash: 2.55m (+ $8m from Jan 28 offering, + $17.5m from Feb 19 offering)
Current liabilities: 537k
Current ratio: 6.72
NWC (total current assets - total current liabilities): 3.07m
Monthly Burn rate (net loss / months): 578k
Estimated current cash: 527k
Accumulated deficit: 38m
Book value (Stock holder equity / Shares outstanding): 0.223 (no longer accurate with new SO)
-Receives FDA Fast track for its Oncorpex Immunogene therapy that targets lung cancer
-Sign Exclusive License Agreement with University of Pittsburgh for Potentially Curative Gene Therapy Candidate for Diabetes
-$25m shelf, recent offering 17/01/20 for $1.267m
-2020-01-28: Closes $8m offering
-2020-02-21: Closes $17.5m offering
-Enough cash for 43.5 months! Doesn't need to do another offering for awhile!
-no gap
-Weak open
-Faded all day
-Levels: 4.75, 5.50, 5.75
First Test short of 5.50 with half dollar and VWAP confluence
The 3 bars before the trade was sketchy / very grindy action littered with bid props, in hindsight it looks like the props were their to fill the sellers short orders. Only got one lot filled at 4.49 before it started tanking, didn't want to chase this down as SSR was on, took 20 cents of profit
Execution detail:
Date/time | Symbol | Side | Price | Position |
---|---|---|---|---|
2020-02-26 10:10:48 | GNPX | sell | $5.490 | short |
2020-02-26 10:14:09 | GNPX | buy | $5.310 | 0 |
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!